{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:56:44Z","timestamp":1792166204836,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100008769","name":"Julius-Maximilians-Universit\u00e4t W\u00fcrzburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008769","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00198-020-05612-9","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T17:03:55Z","timestamp":1599066235000},"page":"377-385","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Bone mineral density and fracture risk in adult patients with hypophosphatasia"],"prefix":"10.1007","volume":"32","author":[{"given":"F.","family":"Genest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Clau\u00dfen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Rak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1154-3388","authenticated-orcid":false,"given":"L.","family":"Seefried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,2]]},"reference":[{"issue":"4","key":"5612_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrendo.2016.14","volume":"12","author":"MP Whyte","year":"2016","unstructured":"Whyte MP (2016) Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol 12(4):233\u2013246","journal-title":"Nat Rev Endocrinol"},{"key":"5612_CR2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.metabol.2017.08.013","volume":"82","author":"E Mornet","year":"2018","unstructured":"Mornet E (2018) Hypophosphatasia. Metabolism 82:142\u2013155","journal-title":"Metabolism"},{"issue":"10","key":"5612_CR3","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/ejhg.2014.10","volume":"22","author":"C Hofmann","year":"2014","unstructured":"Hofmann C et al (2014) Unexpected high intrafamilial phenotypic variability observed in hypophosphatasia. Eur J Hum Genet 22(10):1160\u20131164","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"5612_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bone.2013.01.024","volume":"54","author":"KE Berkseth","year":"2013","unstructured":"Berkseth KE et al (2013) Clinical spectrum of hypophosphatasia diagnosed in adults. Bone 54(1):21\u201327","journal-title":"Bone"},{"key":"5612_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.bone.2016.08.019","volume":"93","author":"MP Whyte","year":"2016","unstructured":"Whyte MP, Wenkert D, Zhang F (2016) Hypophosphatasia: natural history study of 101 affected children investigated at one research center. Bone 93:125\u2013138","journal-title":"Bone"},{"key":"5612_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.bone.2015.02.022","volume":"75","author":"MP Whyte","year":"2015","unstructured":"Whyte MP et al (2015) Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients. Bone 75:229\u2013239","journal-title":"Bone"},{"issue":"4","key":"5612_CR7","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00223-015-0079-1","volume":"98","author":"JL Millan","year":"2016","unstructured":"Millan JL, Whyte MP (2016) alkaline phosphatase and hypophosphatasia. Calcif Tissue Int 98(4):398\u2013416","journal-title":"Calcif Tissue Int"},{"issue":"7","key":"5612_CR8","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/jbmr.2178","volume":"29","author":"FE McKiernan","year":"2014","unstructured":"McKiernan FE, Berg RL, Fuehrer J (2014) Clinical and radiographic findings in adults with persistent hypophosphatasemia. J Bone Miner Res 29(7):1651\u20131660","journal-title":"J Bone Miner Res"},{"key":"5612_CR9","doi-asserted-by":"crossref","unstructured":"Lopez-Delgado L et al (2018) Abnormal bone turnover in individuals with low serum alkaline phosphatase. Osteoporos Int","DOI":"10.1007\/s00198-018-4571-0"},{"issue":"6","key":"5612_CR10","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/S0002-9440(10)62481-9","volume":"166","author":"HC Anderson","year":"2005","unstructured":"Anderson HC et al (2005) Sustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase\/nucleotide pyrophosphatase phosphodiesterase 1 double-deficient mice. Am J Pathol 166(6):1711\u20131720","journal-title":"Am J Pathol"},{"issue":"10","key":"5612_CR11","doi-asserted-by":"publisher","first-page":"e10223","DOI":"10.1002\/jbm4.10223","volume":"3","author":"K Rassie","year":"2019","unstructured":"Rassie K et al (2019) Bisphosphonate use and fractures in adults with hypophosphatasia. JBMR Plus 3(10):e10223","journal-title":"JBMR Plus"},{"key":"5612_CR12","doi-asserted-by":"crossref","unstructured":"Alonso N et al (2019) Loss-of-function mutations in the ALPL gene presenting with adult onset osteoporosis and low serum concentrations of total alkaline phosphatase. J Bone Miner Res","DOI":"10.1002\/jbmr.3928"},{"issue":"3","key":"5612_CR13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jocd.2017.06.014","volume":"20","author":"RK Jain","year":"2017","unstructured":"Jain RK, Vokes T (2017) Dual-energy X-ray absorptiometry. J Clin Densitom 20(3):291\u2013303","journal-title":"J Clin Densitom"},{"issue":"3","key":"5612_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11914-010-0018-z","volume":"8","author":"EM Lewiecki","year":"2010","unstructured":"Lewiecki EM (2010) Bone densitometry and vertebral fracture assessment. Curr Osteoporos Rep 8(3):123\u2013130","journal-title":"Curr Osteoporos Rep"},{"issue":"3","key":"5612_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jbspin.2006.06.017","volume":"74","author":"HJ Girschick","year":"2007","unstructured":"Girschick HJ et al (2007) Long-term follow-up of bone mineral density in childhood hypophosphatasia. Joint Bone Spine 74(3):263\u2013269","journal-title":"Joint Bone Spine"},{"issue":"9","key":"5612_CR16","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s00198-017-4087-z","volume":"28","author":"T Schmidt","year":"2017","unstructured":"Schmidt T et al (2017) Clinical, radiographic and biochemical characteristics of adult hypophosphatasia. Osteoporos Int 28(9):2653\u20132662","journal-title":"Osteoporos Int"},{"key":"5612_CR17","doi-asserted-by":"crossref","unstructured":"Genest F, Seefried L (2018) Subtrochanteric and diaphyseal femoral fractures in hypophosphatasia-not atypical at all. Osteoporos Int","DOI":"10.1007\/s00198-018-4552-3"},{"issue":"6","key":"5612_CR18","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1359\/jbmr.081253","volume":"24","author":"MP Whyte","year":"2009","unstructured":"Whyte MP (2009) Atypical femoral fractures, bisphosphonates, and adult hypophosphatasia. J Bone Miner Res 24(6):1132\u20131134","journal-title":"J Bone Miner Res"},{"issue":"5","key":"5612_CR19","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/jbmr.1565","volume":"27","author":"RA Sutton","year":"2012","unstructured":"Sutton RA et al (2012) \u201cAtypical femoral fractures\u201d during bisphosphonate exposure in adult hypophosphatasia. J Bone Miner Res 27(5):987\u2013994","journal-title":"J Bone Miner Res"},{"issue":"4","key":"5612_CR20","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1210\/jc.2006-1902","volume":"92","author":"MP Whyte","year":"2007","unstructured":"Whyte MP, Mumm S, Deal C (2007) Adult hypophosphatasia treated with teriparatide. J Clin Endocrinol Metab 92(4):1203\u20131208","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"5612_CR21","doi-asserted-by":"publisher","first-page":"7035","DOI":"10.1016\/j.actbio.2013.02.002","volume":"9","author":"V Alt","year":"2013","unstructured":"Alt V et al (2013) A new metaphyseal bone defect model in osteoporotic rats to study biomaterials for the enhancement of bone healing in osteoporotic fractures. Acta Biomater 9(6):7035\u20137042","journal-title":"Acta Biomater"},{"issue":"8","key":"5612_CR22","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1302\/0301-620X.97B8.35032","volume":"97-b","author":"M Kherad","year":"2015","unstructured":"Kherad M et al (2015) The number and characteristics of prevalent vertebral fractures in elderly men are associated with low bone mass and osteoporosis. Bone Joint J 97-b(8):1106\u20131110","journal-title":"Bone Joint J"},{"issue":"6","key":"5612_CR23","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jpeds.2008.12.021","volume":"154","author":"M Tadokoro","year":"2009","unstructured":"Tadokoro M et al (2009) New bone formation by allogeneic mesenchymal stem cell transplantation in a patient with perinatal hypophosphatasia. J Pediatr 154(6):924\u2013930","journal-title":"J Pediatr"},{"issue":"7","key":"5612_CR24","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/ard.48.7.571","volume":"48","author":"AJ Chuck","year":"1989","unstructured":"Chuck AJ et al (1989) Crystal deposition in hypophosphatasia: a reappraisal. Ann Rheum Dis 48(7):571","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"5612_CR25","first-page":"1244","volume":"17","author":"MN Lassere","year":"1990","unstructured":"Lassere MN, Jones JG (1990) Recurrent calcific periarthritis, erosive osteoarthritis and hypophosphatasia: a family study. J Rheumatol 17(9):1244\u20131248","journal-title":"J Rheumatol"},{"key":"5612_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bone.2017.02.011","volume":"102","author":"MP Whyte","year":"2017","unstructured":"Whyte MP (2017) Hypophosphatasia: an overview For 2017. Bone 102:15\u201325","journal-title":"Bone"},{"issue":"6","key":"5612_CR27","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/jbmr.5650110617","volume":"11","author":"BEC Nordin","year":"1996","unstructured":"Nordin BEC et al (1996) Regional bone mineral density interrelationships in normal and osteoporotic postmenopausal women. J Bone Miner Res 11(6):849\u2013856","journal-title":"J Bone Miner Res"},{"issue":"4","key":"5612_CR28","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/0002-9343(82)90474-0","volume":"72","author":"MP Whyte","year":"1982","unstructured":"Whyte MP, Murphy WA, Fallon MD (1982) Adult hypophosphatasia with chondrocalcinosis and arthropathy. Variable penetrance of hypophosphatasemia in a large Oklahoma kindred. Am J Med 72(4):631\u2013641","journal-title":"Am J Med"},{"issue":"4","key":"5612_CR29","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/jbmr.2110","volume":"29","author":"N Gua\u00f1abens","year":"2014","unstructured":"Gua\u00f1abens N et al (2014) Calcific periarthritis as the only cclinical manifestation of hypophosphatasia in middle-aged sisters. J Bone Miner Res 29(4):929\u2013934","journal-title":"J Bone Miner Res"},{"issue":"9","key":"5612_CR30","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.4065\/83.9.1032","volume":"83","author":"MT Drake","year":"2008","unstructured":"Drake MT, Clarke BL, Khosla S (2008) Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc 83(9):1032\u20131045","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"5612_CR31","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1172\/JCI83731","volume":"127","author":"L Seefried","year":"2017","unstructured":"Seefried L et al (2017) Efficacy of anti-sclerostin monoclonal antibody BPS804 in adult patients with hypophosphatasia. J Clin Invest 127(6):2148\u20132158","journal-title":"J Clin Invest"},{"key":"5612_CR32","unstructured":"Camacho PM et al (2016) Adult hypophosphatasia treated with teriparatide: report of two patients and review of the literature. Endocr Pract"},{"issue":"12","key":"5612_CR33","doi-asserted-by":"publisher","first-page":"5174","DOI":"10.1210\/jc.2010-1168","volume":"95","author":"C Schalin-Jantti","year":"2010","unstructured":"Schalin-Jantti C et al (2010) Parathyroid hormone treatment improves pain and fracture healing in adult hypophosphatasia. J Clin Endocrinol Metab 95(12):5174\u20135179","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-020-05612-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-020-05612-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-020-05612-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T23:35:18Z","timestamp":1630539318000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-020-05612-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["5612"],"URL":"https:\/\/doi.org\/10.1007\/s00198-020-05612-9","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,2]]},"assertion":[{"value":"29 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"FG reports personal fees from Abbvie, Alexion, and Lilly. LS reports personal fees from Abbvie, Amgen, Alexion, KyowaKirin, Lilly, Medi, MSD, Novartis, Servier, and UCB and research grants to the Institution (University of Wuerzburg) from Alexion, Kyowa Kirin, and Novartis. LC and DR have nothing to disclose during the study course.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study protocol was approved by the competent ethics committee at Wuerzburg University (Nr. 20180105 01).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"n.a. (retrospective chart review)","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate\/publication"}}]}}